REG - Optima Health PLC - Director/PDMR Shareholding

Optima HealthAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260428:nRSb1102Ca&default-theme=true

RNS Number : 1102C  Optima Health PLC  28 April 2026

28 April 2026

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

Director / PDMR Dealings

Optima Health (AIM: OPT), the UK's leading provider of technology enabled
corporate health and wellbeing solutions, announces that following Admission
of the Open Offer shares on 23 April 2026, the Directors / PDMRs, Julie
Robertson, Jonathan Thomas, Heidi Giles, Simon Arnold, Adam Councell and
Joanne Newey have subscribed for an aggregate of 51,560 Open Offer Shares,
representing approximately 0.05% of the Company's enlarged issued share
capital.

Details of the Ordinary Shares held by each of the Directors/PDMRs are
detailed below:

 Director/PDMR    Current shareholding     % of issued share capital  Shareholding immediately following Admission  % of the enlarged issued share capital following Admission
 Julia Robertson  21,500 Ordinary Shares   0.02                       26,343                                        0.02
 Jonathan Thomas  218,356 Ordinary Shares  0.25                       229,856                                       0.21
 Heidi Giles      83,228 Ordinary Shares   0.09                       92,000                                        0.08
 Simon Arnold     20,451 Ordinary Shares   0.02                       32,100                                        0.03
 Adam Councell    34,608 Ordinary Shares   0.04                       42,404                                        0.04
 Joanne Newey     84,080 Ordinary Shares   0.09                       91,080                                        0.08

Capitalised terms used but not defined in this announcement shall have the
meaning ascribed to such terms in the Circular unless the context requires
otherwise.

 

 Optima Health                                           +44(0) 33 0008 5113

 Jonathan Thomas, CEO                                    media@OptimaHealth.co.uk

 Heidi Giles, CFO

 Nominated Adviser and Joint Corporate Broker

 Panmure Liberum Limited                                 +44 (0)20 3100 2000

 Emma Earl / Will Goode/ Mark Rogers

 Rupert Dearden

 Debt Advisory (sole debt adviser on the transaction):

 Dan Howlett / Ben Handler

 Joint Corporate Broker                                  + 44 (0)20 7220 0500

 Cavendish Capital Markets

 Geoff Nash / Ben Jeynes / George Lawson

 Julian Morse / Michael Johnson/ Nigel Birks

 UK Financial PR Adviser                                 optimahealth@icrinc.com

 ICR Healthcare

 Mary-Jane Elliott / Angela Gray / Lindsey Neville

UK Financial PR Adviser

 ICR Healthcare

 Mary-Jane Elliott / Angela Gray / Lindsey Neville

 optimahealth@icrinc.com

UK Financial PR Adviser

ICR Healthcare

Mary-Jane Elliott / Angela Gray / Lindsey Neville

optimahealth@icrinc.com

 

About Optima

Optima is the UK's leading provider of occupational health and wellbeing
services, directly influencing and improving people's lives for 25 years.
Optima's incredible team of professionals quickly and effectively encapsulate
client's needs, supporting organisations of all shapes and sizes. Through
tailored solutions and innovative systems, Optima offers unparalleled clinical
expertise to its clients. These solutions ensure that processes are simple and
allow its clients to spend more time focusing on their employees driving a
healthy, high-performing workplace. For more information visit www.optima
health.co.uk.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         1.     Julia Robertson

                                                                   2.     Jonathan Thomas

                                                                   3.     Heidi Giles

                                                                   4.     Simon Arnold

                                                                   5.     Adam Councell

                                                                   6.     Joanne Newey
 2    Reason for the notification

 a)   Position/status                                              1.     Non-Executive Chairman

                                                                   2.     Chief Executive Officer

                                                                   3.     Chief Financial Officer

                                                                   4.     Non-Executive Director

                                                                   5.     Non-Executive Director

                                                                   6.     Chief Commercial Officer (PDMR)
 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Optima Health plc

 b)   LEI                                                          213800TOPWJSRCW4ON08

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of £0.01 each

      Identification code                                          GB00BRSCY602

 b)   Nature of the transaction                                    Purchase of shares

 c)   Price(s) and volume(s)

                                                                                     Purchase Price                Volume
                                                                                     175 pence per Ordinary Share  1.     4,843

                                                                                                                   2.     11,500

                                                                                                                   3.     8,772

                                                                                                                   4.     11,649

                                                                                                                   5.     7,796

                                                                                                                   6.     7,000

 d)   Aggregated information

      - Aggregated volume                                          51,560 shares
                                                                   175.00 pence
      - Price

 e)   Date of the transaction                                      23 April 2026

 f)   Place of the transaction                                     London Stock Exchange, AIM Market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHSEDESWEMSEDL



            Copyright 2019 Regulatory News Service, all rights reserved